Treatment of stage IIIA non-small cell lung cancer

Lary A. Robinson, Henry Wagner, John C. Ruckdeschel

Research output: Contribution to journalReview articlepeer-review

101 Scopus citations

Abstract

Stage IIIA non-small cell lung cancer represents a relatively heterogeneous group of patients with metastatic disease to the ipsilateral mediastinal (N2) lymph nodes and also includes T3N1 patients. Presentations of disease range from apparently resectable tumors with occult microscopic nodal metastases to unresectable, bulky multistation nodal disease. Controversy abounds as to the optimal treatment of the various stage IIIA subsets, which is fueled by a lack of meaningful, large randomized trials. Multimodality therapy of some type appears to be preferable in stage IIIA patients.

Original languageEnglish (US)
Pages (from-to)202S-220S
JournalCHEST
Volume123
Issue number1 SUPPL.
DOIs
StatePublished - 2003

All Science Journal Classification (ASJC) codes

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine
  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Treatment of stage IIIA non-small cell lung cancer'. Together they form a unique fingerprint.

Cite this